IGC Pharma, Inc. came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
Feed from Fxstreet.com